tiprankstipranks
Trending News
More News >

EQL Pharma Achieves Significant Growth and Expands Market Reach

Story Highlights
EQL Pharma Achieves Significant Growth and Expands Market Reach

Don’t Miss TipRanks’ Half-Year Sale

EQL Pharma AB ( (SE:EQL) ) has issued an announcement.

EQL Pharma AB reported a successful year-end with a 45% increase in sales and a 174% rise in operating profit, driven by the acquisition of new products and a significant distribution deal outside Europe. The company has surpassed its five-year growth targets and is poised for continued expansion with a new strategic plan aiming for a 30% sales growth in the coming year.

More about EQL Pharma AB

EQL Pharma AB operates in the pharmaceutical industry, focusing on the development and distribution of niche generic drugs. The company is expanding its market presence with a significant emphasis on non-European markets, as evidenced by its recent distribution agreement in the Gulf countries.

Average Trading Volume: 20,129

Current Market Cap: SEK2.3B

Find detailed analytics on EQL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1